DGCI approves vaccine for children 2-18 years age group

Aaj Tak 2021-10-12

Views 1

The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. The made in India vaccine will be administered in two doses, with a gap of 20 days between the first and second dose. Watch this episode of Non-stop 100.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Britain approves Pfizer vaccine for 12-15 aged children
play
05:57

Britain approves Pfizer vaccine for 12-15 aged children
COVID-19: DCGI approves study on mixing vaccines
play
04:04

COVID-19: DCGI approves study on mixing vaccines
U.K. approves Pfizer coronavirus vaccine
play
00:28

U.K. approves Pfizer coronavirus vaccine
UK approves Pfizer-BioNTech Covid vaccine
play
19:28

UK approves Pfizer-BioNTech Covid vaccine
Russia approves first coronavirus vaccine
play
04:11

Russia approves first coronavirus vaccine
US approves Pfizer Covid-19 vaccine for kids
play
20:12

US approves Pfizer Covid-19 vaccine for kids
SEC approves vaccine for kids, all you need to know
play
29:02

SEC approves vaccine for kids, all you need to know
Corona vaccine administered to 15-18 age group at centres
play
03:30

Corona vaccine administered to 15-18 age group at centres
When will children below 15 years get vaccine?
play
05:52

When will children below 15 years get vaccine?
Children above 12 years will also get corona vaccine!
play
17:39

Children above 12 years will also get corona vaccine!
Maha delays vaccination drive for 18-44 years age group
play
05:30

Maha delays vaccination drive for 18-44 years age group
Covaxin gets approval for children of 2-18 years age group
play
16:26

Covaxin gets approval for children of 2-18 years age group